The Effect of ENZAlutamide on the Anti-Xa Levels of Patients Receiving DOACs
Clinical trial NCT03920566 · UNKNOWN
Trial details
- NCT number
- NCT03920566
- Sponsor
- Royal Marsden NHS Foundation Trust
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2019-05-01
- Primary completion
- 2020-04-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.